Citadel Advisors »

Corbus Pharmaceuticals Hldgs shares owned by Citadel Advisors

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $699k 59k 11.80
2024-09-30 $2.7M 130k 20.63
2024-06-30 $16M 347k 45.25
2024-03-31 $15M 387k 39.24

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon Call Option (AMZN)
Microstrategy Cl A New Call Option (MSTR)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Advanced Micro Devices Call Option (AMD)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
OrbiMed Advisors
Octagon Capital Advisors
BlackRock
Vanguard Group
Adage Capital Partners GP
Jane Street
Millennium Management
Ghost Tree Capital
Prosight Management
Geode Capital Management
Tang Capital Management
Armistice Capital
State Street Corporation
Altium Capital Management

View all funds holding Corbus Pharmaceuticals Hldgs